SOFIA (Bulgaria), September 24 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday that its CEO Ognyan Donev further increased his interest in the company through a single transaction on the regulated market of the Bulgarian Stock Exchange on September 23.